Letters/Comments

AHA letters and comments provide insight to legislators and policymakers about laws and regulations important to the healthcare field.

AHA letter to Representative Charles Dent endorsing HR 3537, the Synthetic Drug Control Act of 2015.
AHA strongly supports many of the provisions of the Health Benefit Plan Network Access and Adequacy Model Act (Model Act) as approved by the National Association of Insurance Commissioners' (NAIC) Regulatory Framework (B) Task Force.